J. Goldman & Co LP - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 34 filers reported holding SCPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$625,898
+9.2%
87,907
+56.3%
0.02%
+4.8%
Q2 2023$573,208
-6.4%
56,252
-16.7%
0.02%
-16.0%
Q1 2023$612,243
-51.8%
67,502
-61.9%
0.02%
-59.7%
Q4 2022$1,269,728
+284.8%
177,089
+249.8%
0.06%
+287.5%
Q3 2022$330,000
-13.8%
50,625
-25.0%
0.02%
-5.9%
Q1 2022$383,000
-79.4%
67,500
-81.8%
0.02%
-83.3%
Q4 2021$1,858,000
-64.7%
370,091
-53.3%
0.10%
-61.4%
Q3 2021$5,270,000
+19.6%
792,421
+9.9%
0.26%
+54.4%
Q2 2021$4,405,000
+233.7%
720,877
+263.3%
0.17%
+307.1%
Q1 2021$1,320,000198,4260.04%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,831,474$20,268,0006.83%
AIGH Capital Management LLC 637,322$3,372,0001.37%
Worth Venture Partners, LLC 162,875$862,0000.68%
Ikarian Capital, LLC 1,466,147$7,756,0000.34%
RA Capital Management 3,518,998$18,615,0000.26%
Orbimed Advisors 4,797,148$25,377,0000.22%
DAFNA Capital Management LLC 38,891$206,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 150,699$797,0000.03%
Alyeska Investment Group, L.P. 355,690$1,882,0000.03%
ALGERT GLOBAL LLC 13,860$73,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders